Primary Vaccination: Individuals 9 months of age and over: A 0.5 mL single injection of the reconstituted vaccine.
Booster: Adult Population (18 years of age and over): There is no need for a booster dose up to 5 years after the administration of a single dose of IMOJEV.
Paediatric Population (9 months to 17 years of age inclusive): A booster dose of IMOJEV should be given after primary vaccination in order to confer long term protection. The booster dose should be given preferably 12 months after primary vaccination and can be given up to 24 months after primary vaccination.
IMOJEV can also be given as a booster vaccination in children who were previously given an inactivated Japanese Encephalitis (JE) vaccine for primary vaccination, in accordance with the recommended timing for the booster of the inactivated JE vaccine.
Safety and efficacy of a booster dose in children and adolescents 5 to 17 years have not been established. Nevertheless, the booster dose can be considered based on the available data in other age group.
Once the freeze-dried vaccine has been completely reconstituted using the diluent provided (see Instructions for Use under Cautions for Usage), it is administered via the subcutaneous route.
In individuals 2 years of age and older, the recommended injection site is the deltoid region of the upper arm.
In individuals between 9 and 24 months of age, the recommended injection site is the anterolateral aspect of the thigh or the deltoid region.
Do not administer by intravascular injection.
IMOJEV must not be mixed with any other injectable vaccine(s) or medicinal product(s).
Contact with disinfectants is to be avoided since they may inactivate the vaccine virus.
Product is for single use in one patient only. Discard any residue.